Advertisement
Alice Long joins Diamyd Medical’s Scientific Advisory Board

Alice Long, a leading expert in translational immunology and diabetes research, has joined Diamyd Medical’s Scientific Advisory Board (SAB).
Long brings extensive experience in immunology and research aimed at understanding how individuals respond to immunotherapies, states Diamyd.
“We are honored to welcome Dr. Long to Diamyd Medical’s SAB,” says Mark Atkinson, Chairman of Diamyd Medical’s Scientific Advisory Board and Board member of Diamyd Medical. “Her landmark research around precision medicine and translation research for Type 1 Diabetes is fully aligned with the targeted approach of Diamyd. Her support will be vital in shaping the scientific awareness and positioning our therapy.”
Alice Long
Alice Long is an Associate Member and Principal Investigator at the Center for Translational Immunology at Benaroya Research Institute. Long’s translational immunology lab investigates the mechanisms behind the loss of immune tolerance in autoimmune diseases and explores therapeutic strategies to restore it. Her research spans three interconnected areas: understanding the diminished IL-2 response in autoimmune patients, defining the function and stability of CD8 T cell exhaustion linked to favorable outcomes in autoimmunity, and uncovering factors that influence differential responses to therapy among patients.
“I am excited to join Diamyd Medical in its mission to transform care for individuals with Type 1 Diabetes,” says Alice Long. “The company’s focus on innovative therapies and precision medicine resonates deeply with my research goals. I look forward to collaborating with the team to advance groundbreaking treatments that improve patient outcomes and redefine the possibilities for managing autoimmune diseases.”
Updated: January 13, 2025, 02:31 pm
Published: January 9, 2025
Advertisement